Velpatasvir

ATC — · 11 markets · 41 records

Velpatasvir 11 markets · 41 records Forms

Filters

MarketGB 7 US 6 AU 6 ES 6 FR 5 CA 2 SG 2 TW 2 HK 2 EU 2 MX 1

Kind

Strength

GB 7 records · 5 shown of 5 Source NHSBSA dm+d · Data as of 2026-10-19

Combination products containing this ingredient

100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa+1Manufacturer: Gilead Sciences Ltd also in US·AU·ES
+3Other 3 markets
FR CA SG
50 mgtablet CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa also in US·FR
50 mgpowder CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa 200mg/50mg granules sachets also in FR
37.5 mgpowder CombinationSofosbuvir 150 mg + Velpatasvir 37.5 mgEpclusa 200mg/50mg granules sachets
100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi+1Manufacturer: Gilead Sciences Ltd also in US·AU·FR
+2Other 2 markets
CA SG

US 6 records · 5 shown of 5 Source openFDA NDC Directory · Data as of 2026-10-23

Combination products containing this ingredient

100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa+1Sofosbuvir and Velpatasvir also in GB·AU·ES
+3Other 3 markets
FR CA SG
50 mgtablet CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa also in GB·FR
50 mgpellet CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa
37.5 mgpellet CombinationSofosbuvir 150 mg + Velpatasvir 37.5 mgEpclusa
100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi also in GB·AU·FR
+2Other 2 markets
CA SG

AU 6 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa+1EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle also in GB·US·ES
+3Other 3 markets
FR CA SG
unknown
100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi+1VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle also in GB·US·FR
+2Other 2 markets
CA SG
unknown

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Epclusa ×6Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

ES 6 records · 3 shown of 3 Source CIMA (AEMPS) · Data as of live · some records have no stated strength

Combination products containing this ingredient

100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa also in GB·US·AU
+3Other 3 markets
FR CA SG
50 mgliquid CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEpclusa
37.5 mgliquid CombinationSofosbuvir 150 mg + Velpatasvir 37.5 mgEpclusa

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 5 records · 5 shown of 5 Source Base de données publique des médic · Data as of 2026-11-03

Combination products containing this ingredient

100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEPCLUSA 200 mg/50 mg, comprimé pelliculé also in GB·US·AU
+3Other 3 markets
ES CA SG
50 mgtablet CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEPCLUSA 200 mg/50 mg, comprimé pelliculé also in GB·US
50 mgpowder CombinationSofosbuvir 200 mg + Velpatasvir 50 mgEPCLUSA 150 mg/37,5 mg, granulés enrobés en sachet also in GB
37.05 mgpowder CombinationSofosbuvir 150 mg + Velpatasvir 37.05 mgEPCLUSA 150 mg/37,5 mg, granulés enrobés en sachet
100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVOSEVI 400 mg/100 mg/100 mg, comprimé pelliculé also in GB·US·AU
+2Other 2 markets
CA SG

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Combination products containing this ingredient

100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa also in GB·US·AU
+3Other 3 markets
ES FR SG
100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi also in GB·US·AU
+2Other 2 markets
FR SG

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mgEpclusa also in GB·US·AU
+3Other 3 markets
ES FR CA
100 mgtablet CombinationSofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mgVosevi also in GB·US·AU
+2Other 2 markets
FR CA

TW 2 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Epclusa ×6Vosevi ×6宜譜莎膜衣錠 ×1沃士維膜衣錠 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Epclusa ×6Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 2 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Epclusa ×6Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Vosevi ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU	FR
100 mg Combination Sofosbuvir 400 mg + Velpatasvir 100 mg tablet	Epclusa Sofosbuvir and Velpatasvir	Manufacturer: Gilead Sciences Ltd ×2 Epclusa	Epclusa	Epclusa EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle	Epclusa	Epclusa	not recorded	not recorded	not recorded	not recorded	EPCLUSA 200 mg/50 mg, comprimé pelliculé
50 mg Combination Sofosbuvir 200 mg + Velpatasvir 50 mg tablet	Epclusa	Epclusa	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	EPCLUSA 200 mg/50 mg, comprimé pelliculé
50 mg Combination Sofosbuvir 200 mg + Velpatasvir 50 mg powder	not recorded	Epclusa 200mg/50mg granules sachets	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	EPCLUSA 150 mg/37,5 mg, granulés enrobés en sachet
50 mg Combination Sofosbuvir 200 mg + Velpatasvir 50 mg liquid	not recorded	not recorded	not recorded	not recorded	not recorded	Epclusa	not recorded	not recorded	not recorded	not recorded	not recorded
37.5 mg Combination Sofosbuvir 150 mg + Velpatasvir 37.5 mg liquid	not recorded	not recorded	not recorded	not recorded	not recorded	Epclusa	not recorded	not recorded	not recorded	not recorded	not recorded
37.5 mg Combination Sofosbuvir 150 mg + Velpatasvir 37.5 mg powder	not recorded	Epclusa 200mg/50mg granules sachets	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
37.05 mg Combination Sofosbuvir 150 mg + Velpatasvir 37.05 mg powder	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	EPCLUSA 150 mg/37,5 mg, granulés enrobés en sachet
50 mg Combination Sofosbuvir 200 mg + Velpatasvir 50 mg pellet	Epclusa	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
37.5 mg Combination Sofosbuvir 150 mg + Velpatasvir 37.5 mg pellet	Epclusa	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg Combination Sofosbuvir 400 mg + Velpatasvir 100 mg + Voxilaprevir 100 mg tablet	Vosevi	Manufacturer: Gilead Sciences Ltd ×2 Vosevi	Vosevi	Vosevi VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle	Vosevi	not recorded	not recorded	not recorded	not recorded	not recorded	VOSEVI 400 mg/100 mg/100 mg, comprimé pelliculé
not disclosed Combination Sofosbuvir + Velpatasvir unknown	not recorded	not recorded	not recorded	Epclusa	not recorded	not recorded	not recorded	not recorded	Epclusa	Epclusa	not recorded
not disclosed Combination Sofosbuvir + Velpatasvir tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Epclusa 宜譜莎膜衣錠	not recorded	not recorded	not recorded
not disclosed Combination Sofosbuvir + Velpatasvir + Voxilaprevir tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Vosevi	Vosevi 沃士維膜衣錠	not recorded	not recorded	not recorded
not disclosed Combination Sofosbuvir + Velpatasvir + Voxilaprevir unknown	not recorded	not recorded	not recorded	Vosevi	not recorded	not recorded	not recorded	not recorded	Vosevi	Vosevi	not recorded
not disclosed Combination Sofosbuvir 100 mg + Velpatasvir + Voxilaprevir tablet	not recorded	not recorded	not recorded	not recorded	not recorded	Vosevi	not recorded	not recorded	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

6 more strength/form rows are recorded only in ES · MX · TW · FR and are not shown in this table. Hay 6 filas de concentración/forma registradas solo en ES · MX · TW · FR que no se muestran en esta tabla. 另有 6 个规格/剂型仅在 ES · MX · TW · FR 有记录（未在本表显示）。另有 6 個規格/劑型僅在 ES · MX · TW · FR 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.